» Articles » PMID: 2397212

Expression and Characterization of Recombinant Human Factor V and a Mutant Lacking a Major Portion of the Connecting Region

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1990 Jul 24
PMID 2397212
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Human coagulation factor V is a protein cofactor that is an essential component of the prothrombinase complex. A full-length factor V cDNA has been subcloned into the mammalian expression vector pDX and used to transfect COS cells. Approximately 95 +/- 4% of the recombinant human factor V (rHFV) synthesized in COS cells is secreted into the culture medium. Forty-eight hours after transfection rHFV antigen levels in the conditioned medium were 70 +/- 15 ng/mL. Factor V activity determined by fibrometer assay increased approximately 5-fold from 0.027 +/- 0.012 to 0.124 +/- 0.044 unit/mL following activation by the factor V activating enzyme from Russell's viper venom (RVV-V). A chromogenic assay specific for factor Va indicated that recombinant factor V had 3.8 +/- 1.3% of the activity of the activated protein. The estimated specific activity of the recombinant factor Va was approximately 1800 +/- 500 units/mg, which is similar to the specific activity of purified plasma factor Va of 1700-2000 units/mg. Immunoprecipitation of [35S]methionine-labeled rHFV revealed a single high molecular mass component (approximately 330 kDa). Treatment of rHFV with thrombin or RVV-V resulted in the formation of proteolytic products that were similar to those seen with plasma factor V. We have also expressed a mutant, rHFV-des-B811-1441, that lacks a large portion of the highly glycosylated connecting region that is present in factor V. Immunoprecipitation of [35S]methionine-labeled rHFV-des-B811-1441 revealed a single-chain polypeptide with Mr approximately 230 kDa. This mutant constitutively expressed 38 +/- 7% of the activity of the RVV-V-activated protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.

Petrillo T, Ayombil F, Vant Veer C, Camire R J Biol Chem. 2020; 296:100234.

PMID: 33376137 PMC: 7948760. DOI: 10.1074/jbc.RA120.016341.


Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.

Wiencek J, Na M, Hirbawi J, Kalafatis M J Biol Chem. 2013; 288(52):37026-38.

PMID: 24178294 PMC: 3873559. DOI: 10.1074/jbc.M113.462374.


Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Bunce M, Bos M, Krishnaswamy S, Camire R J Biol Chem. 2013; 288(42):30151-30160.

PMID: 24014022 PMC: 3798483. DOI: 10.1074/jbc.M113.506840.


A bipartite autoinhibitory region within the B-domain suppresses function in factor V.

Bos M, Camire R J Biol Chem. 2012; 287(31):26342-51.

PMID: 22707727 PMC: 3406718. DOI: 10.1074/jbc.M112.377168.


Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Bos M, Camire R J Coagul Disord. 2010; 2(2):19-27.

PMID: 21165149 PMC: 3001592.